Kevin J. Ballinger, EVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 85,606 shares at $28.31 ($2.4M) on 2018-03-14, disclosed to the SEC on 2018-03-15.
Seasonal sale ($2.4M) by EVP & President, Interven Cardio — this insider has traded BSX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.31 | 33,428 | $946K | 39.0% |
| 2 | $28.31 | 33,428 | $946K | 39.0% |
| 3 | $28.37 | 9,375 | $266K | 11.0% |
| 4 | $28.37 | 9,375 | $266K | 11.0% |
| Total | $28.32 avg | 85,606 | $2.4M | 100% |
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |